Synergism of benflumetol and artemether in Plasmodium falciparum

American Journal of Tropical Medicine and Hygiene

Volumn 61, Issue 3, 1999, Pages 439-445

  Alin, M Hassan ^a   Bjorkman A ^b   Wernsdorfer, W H ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; ARTEMISIN DERIVATIVE; BENFLUMETOL; CHLOROQUINE; MEFLOQUINE;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG STRUCTURE; NONHUMAN; NUCLEIC ACID SYNTHESIS; PLASMODIUM FALCIPARUM; PROTEIN SYNTHESIS INHIBITION;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0344549158     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.61.439     Document Type: Article

References (29)

1. World Health Organization, 1990. Practical chemotherapy of malaria. World Health Organ Tech Rep Ser 805.
2. Karbwang J, Na Bangchang K, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T, 1992. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria. Lancet 340: 1245-1248.
3. Jiao X, Liu G Y, Shan C O, Zhao X, Li X W, Gathmann I, Royce C, 1997. Phase II trial in China of a new, rapidly-acting and oral antimalarial, CGP 56697, for the treatment of Plasmodiuin falciparum malaria. Southeast Asian J Trop Med Public Health 28: 476-481.
4. von Seidlein L, Jaffar S, Pinder M, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, Greenwood B, 1997. Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug. CGP 56697. J Infect Dis 176: 1113-1116.
5. von Seidlein L, Bojang K, Jones P, Jaffar S, Pinder M, Obaro S, Doherty T, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, McAdam K, Greenwood B, 1998. Randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. Am J Trop Med Hyg 58: 638-644.
6. Hatz C, Abdulla S, Mull R, Schellenberg D. Gathmann I, Kibatala R Beck H-P, Tanner M, Royce C, 1998. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years. Trop Med Int Health 3: 498-504.
7. van Vugt M, Brockman A, Gemperli B, Luxemburger C, Gathmann I, Royce C, Thra Slight, Looareesuwan S, White NJ, Nosten F, 1998. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob Agents Chemother 42: 135-139.
8. Olliaro PL, Trigg PI, 1995. Status of antimalarial drugs under development. Bull World Health Organ 73: 565-571.
9. Novartis, 1997. Meeting the Challenge: CGP 56697, a Novel Antimalarial Combination. London: Current Medical Literature Ltd.
10. Alin MH, Björkman A, Ashton M, 1990. In vitro activity of artemisinin, its derivatives and pyronaridine against different strains of Plasmodium falciparum. Trans R Soc Trop Med Hyg 84: 635-637.
11. Shute GT, 1988. The microscopic diagnosis of malaria. Wernsdorfer WH, McGregor IA, eds. Malaria: Principles and Practice of Malariology. Edinburgh: Churchill Livingstone, 781-814.
12. Litchfield JT, Wilcoxon F, 1949. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Therapy 96: 99-113.
13. Daniel WW, 1991. Biostatistics: A Foundation for Analysis in the Health Sciences. Fifth edition. New York: John Wiley & Sons.
14. Wernsdorfer WH, Landgraf B, Kilimali VAEB, Wernsdorfer G, 1998. Activity of benflumetol and its enantiomers in fresh isolates of Plasmodium falciparum from East Africa. Acta Trop 70: 9-15.
15. Pradines B, Rogier C, Fusai T, Tell A, Trape JF, Doury JC, 1998. In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs. Am J Trop Med Hyg 58: 354-357.
16. von Seidlein L, Duraisingh MT, Drakeley CJ, Bailey R, Greenwood BM, Pinder M, 1997. Polymorphism of the Pfmdr 1 gene and chloroquine resistance in Plasmodium falciparum in the Gambia. Trans R Soc Trop Med Hyg 91: 450-453.
17. Kombila M, Huong TH, Dufillot D, Koko J, Guiyedi V, Guigeun C, Ferrer A, Richard-Lenoble D, 1997. Light microscopic change in Plasmodium falciparum from Gabonese children treated with artemether. Am J Trop Med Hyg 57: 643-645.
18. Alin MH, Ashton M, Kihamia CM, Mtey GJ, Bjoerkman A, 1996. Clinical efficacy and pharmacokinetics of artemisinin alone and in combination with mefloquine in patients with falciparum malaria. Br J Pharmacol 41: 587-592.
19. Karbwang J, Na Bangchang K, 1993. Clinical pharmacology of artemisinin compounds. Karbwang J, Wernsdorfer WH, eds. Clinical Pharmacology of Antimalarials. Bangkok: Faculty of Tropical Medicine, Mahidol University, 263-304.
20. Karbwang J, Na-Bangchang K, Congpuong K, Molunto P, Thanavibul A, 1997. Pharmacokinetics and bioavailability of oral and intramuscular artemether. Eur J Pharmacol 52: 307-310.
21. Mordi MN, Mansor SM, Navaratnam V, Wernsdorfer WH, 1997. Single dose pharmacokinetics of oral artemether in healthy Malaysian volunteers. Br J Clin Pharmacol 43: 363-365.
22. Teja-Isavadharm P, Nosten F, Kule DE, Luxemburger C, ter-Kuyle F, Peggins JO, Brewer TG, White NJ, 1996. Comparative bioavailability of oral, rectal and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay. Br J Clin Pharmacol 42: 599-604.
23. Bunnag D, Kanda T, Karbwang J, Thimasarn K, Pungpak S, Harinasuta T, 1995. Artemether-mefloquine combination in multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 89: 213-215.
24. Karbwang J, Na-Bangchang K, Thanavibul A, Ditta M, Harinasuta T, 1995. A comparative trial of two different regimens of artemether plus mefloquine in multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg 89: 296-298.
25. Chawira AN, Warhurst DC, Peters W, 1986. Drug combination studies with qinghaosu (artemisinin) against sensitive and resistant strains of rodent malaria. Trans R Soc Trop Med Hyg 80: 334-335.
26. Bwijo B, Alin MH, Abbas N, Wernsdorfer WH, Bjoerkman A, 1997. Efficacy of artemisinin and mefloquine combinations against Plasmodium falciparum. In vitro simulation of in vivo pharmacokinetics. Trop Med Int Health 2: 461-467.
27. Oduola AM, Omitowoju GO, Soqunni A, Makler MT, Falade CO, Kyle DE, Fehintola FA, Ogundahunsi OPA, Piper RC, Schuster BG, Milhous WK, 1997. Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria. Exp Parasitol 87: 283-289.
28. Ha V, Nguyen NH, Tran TB, Bui MC, Nguyen HP, Tran TH, Phan TQ, Arnold K, Tran TH, 1997. Severe and complicated malaria treated with artemisinin, artesunate and artemether in Vietnam. Trans R Soc Trop Med Hyg 91: 465-467.
29. Wernsdorfer WH, 1994. Epidemiology of drug resistance in malaria. Acta Trop 56: 143-156.